Prestige Consumer Healthcare (PBH) Interest Coverage Ratio Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Interest Coverage Ratio Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -47.39% |
| Sep 30, 2025 | -50.43% |
| Jun 30, 2025 | -50.44% |
| Mar 31, 2025 | 584.41% |
| Dec 31, 2024 | 12.47% |
| Sep 30, 2024 | 7.19% |
| Jun 30, 2024 | 5.47% |
| Mar 31, 2024 | -121.80% |
| Dec 31, 2023 | 21.91% |
| Sep 30, 2023 | -2.34% |
| Jun 30, 2023 | 10.80% |
| Mar 31, 2023 | 460.46% |
| Dec 31, 2022 | 18.79% |
| Sep 30, 2022 | 34.55% |
| Jun 30, 2022 | -18.91% |
| Mar 31, 2022 | -205.31% |
| Dec 31, 2021 | -13.35% |
| Sep 30, 2021 | -8.06% |
| Jun 30, 2021 | 46.72% |
| Mar 31, 2021 | 286.41% |